Bullfrog AI Holdings Inc. Warrants (BFRGW)
Stock · NASDAQ · Health Care
$0.13as of 10/14/2026
Price chart
Active signals
High Beta60.9%
Industry
Biotechnology: Pharmaceutical Preparations
Fundamentals
- 1-day range
- $0.091$0.1598
- Market cap
- $2.04M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- 2.34
- Avg. volume
- —
52-week range
$0.0751$0.6488
Bullfrog AI Holdings Inc. Warrants Competitors
Chosen by industry and closest market cap.
- BFRGWBullfrog AI Holdings Inc. Warrants$0.13▲ 25.85%Market cap $2.04MP/E —$0.0751$0.6488
- SXTCChina SXT Pharmaceuticals Inc. Class A Ordinary Shares$0.065▼ 5.80%Market cap $2.06MP/E —$0.0619$83,758
- AZTRAzitra Inc Common Stock$0.072▲ 0.00%Market cap $2.18MP/E 6.22$0.0518$1.09
- GNPXGenprex Inc. Common Stock$2.11▼ 7.86%Market cap $2.24MP/E —$2.53$1,210
- PPBTPurple Biotech Ltd. American Depositary Shares$1.14▼ 7.32%Market cap $2.29MP/E —$1$2.2
- CMNDClearmind Medicine Inc. Common Shares$6.26▼ 2.49%Market cap $1.78MP/E —$5.25$3,840
- MTNBMatinas Biopharma Holdings Inc. Common Stock$2.37▼ 2.07%Market cap $1.72MP/E —$2.26$28.95
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BFRGW Bullfrog AI Holdings Inc. Warrants | $2.04M | — | $0.13 | ▲ 25.85% | $0.0751$0.6488 |
| SXTC China SXT Pharmaceuticals Inc. Class A Ordinary Shares | $2.06M | — | $0.065 | ▼ 5.80% | $0.0619$83,758 |
| AZTR Azitra Inc Common Stock | $2.18M | 6.22 | $0.072 | ▲ 0.00% | $0.0518$1.09 |
| GNPX Genprex Inc. Common Stock | $2.24M | — | $2.11 | ▼ 7.86% | $2.53$1,210 |
| PPBT Purple Biotech Ltd. American Depositary Shares | $2.29M | — | $1.14 | ▼ 7.32% | $1$2.2 |
| CMND Clearmind Medicine Inc. Common Shares | $1.78M | — | $6.26 | ▼ 2.49% | $5.25$3,840 |
| MTNB Matinas Biopharma Holdings Inc. Common Stock | $1.72M | — | $2.37 | ▼ 2.07% | $2.26$28.95 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- BullFrog AI Advances Major Depressive Disorder Drug Discovery Program With Global Pharma PartnerYahoo · 10/6/2026
- BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive DisorderYahoo · 10/6/2026
- Is Bullfrog AI Holdings Inc. (BFRG) Outperforming Other Medical Stocks This Year?Yahoo · 9/24/2026
- Bullfrog AI Holdings, Inc. (BFRG) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 TranscriptSeekingAlpha · 9/15/2026
- iAccess Alpha Virtual Best Ideas Fall Investment Conference Begins Today with Updated Presentation ScheduleYahoo · 9/15/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 217.0K
- Total value held
- $176.1K
- Institutional holders
- 4
Top holders this quarter
- Unknown109.5K
- Unknown80.8K
- Unknown25.0K
- Unknown1.8K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
BullFrog AI reports progress in MDD drug discovery with pharma partner
BullFrog AI announced that its drug discovery program for major depressive disorder has moved forward through a partnership with a global pharmaceutical company. The collaboration involves a top‑five worldwide pharma firm and reports positive progress in identifying candidate compounds. This development underscores the company's focus on AI‑driven therapeutics as the stock trades within its 52‑week range.
BullFrog AI reports progress in MDD drug discovery with pharma partner. BullFrog AI announced that its drug discovery program for major depressive disorder has moved forward through a partnership with a global pharmaceutical company. The collaboration involves a top‑five worldwide pharma firm and reports positive progress in identifying candidate compounds. This development underscores the company's focus on AI‑driven therapeutics as the stock trades within its 52‑week range.